Leukemia,290
Acute,280
Humans,276
Myeloid,269
Aged,140
Antineoplastic Combined Chemotherapy Protocols,90
Adult,88
Female,85
Male,82
Middle Aged,81
Hematopoietic Stem Cell Transplantation,58
Azacitidine,54
Treatment Outcome,44
Mutation,41
80 and over,41
Cytarabine,41
Myelodysplastic Syndromes,39
Bridged Bicyclo Compounds,37
Heterocyclic,37
Young Adult,35
Recurrence,35
Sulfonamides,34
fms-Like Tyrosine Kinase 3,33
Prognosis,32
Neoplasm,31
Child,30
Antineoplastic Agents,30
Remission Induction,29
Adolescent,27
Graft vs Host Disease,25
Decitabine,23
Prospective Studies,20
Residual,20
Nucleophosmin,19
Transplantation Conditioning,16
Daunorubicin,15
Transplantation,15
Retrospective Studies,15
Quality of Life,14
Animals,12
Isocitrate Dehydrogenase,12
Drug Resistance,12
Mice,12
Local,12
Neoplasm Recurrence,12
Tumor,12
Antibodies,12
Tretinoin,12
Homologous,12
Hematologic Neoplasms,11
Protein Kinase Inhibitors,11
Promyelocytic,10
Tumor Suppressor Protein p53,10
Monoclonal,10
Clinical Trials,9
Cell Line,9
Receptors,9
Chronic,9
Pyrimidines,8
Nuclear Proteins,8
Immunotherapy,8
Myelomonocytic,8
Myeloproliferative Disorders,7
Cyclophosphamide,7
Infant,7
Idarubicin,7
Mitoxantrone,7
Induction Chemotherapy,7
Maximum Tolerated Dose,7
Arsenic Trioxide,7
Tumor Microenvironment,7
Pyrazines,7
Preschool,7
Aniline Compounds,7
Pilot Projects,6
Gemtuzumab,6
Proto-Oncogene Proteins c-bcl-2,6
T-Lymphocytes,6
Acute Disease,6
Disease-Free Survival,6
Randomized Controlled Trials as Topic,6
Antineoplastic,6
Busulfan,6
Neoplasms,5
Killer Cells,5
Natural,5
Unrelated Donors,5
Sorafenib,5
Interleukin-3 Receptor alpha Subunit,5
Risk Assessment,5
Pyridines,5
Aminopyridines,5
Arsenicals,5
Proto-Oncogene Proteins,5
Thrombocytopenia,5
Biomarkers,5
Chronic Disease,5
Adoptive,5
Phase III as Topic,5
Follow-Up Studies,5
Granulocyte Colony-Stimulating Factor,5
Drug,4
CD8-Positive T-Lymphocytes,4
Drug Therapy,4
Combination,4
Protein-Tyrosine Kinases,4
Etoposide,4
Cyclopentanes,4
T-Cell,4
Antigens,4
Triazines,4
Phase I as Topic,4
Risk Factors,4
Flow Cytometry,4
Febrile Neutropenia,4
Apoptosis,4
Phenylurea Compounds,4
Dose-Response Relationship,4
Genetic,4
Core Binding Factor Alpha 2 Subunit,4
Antimetabolites,4
Registries,4
Xenograft Model Antitumor Assays,4
Neoplastic Stem Cells,4
Antigen,4
Cohort Studies,4
Double-Blind Method,4
DNA Methylation,3
Pathologic Complete Response,3
Antibiotics,3
ATP Binding Cassette Transporter,3
Subfamily B,3
Second Primary,3
Antifungal Agents,3
Reactive Oxygen Species,3
Progression-Free Survival,3
Cell Differentiation,3
Myeloid-Lymphoid Leukemia Protein,3
Epigenesis,3
Cytokine Release Syndrome,3
Cord Blood Stem Cell Transplantation,3
Gastrointestinal Microbiome,3
Human,3
Interleukin-15,3
Karyotype,3
Chimeric Antigen,3
Vidarabine,3
Cladribine,3
Drug-Related Side Effects and Adverse Reactions,3
Homoharringtonine,3
Histone-Lysine N-Methyltransferase,3
Immunoconjugates,3
Consolidation Chemotherapy,3
Amlodipine,3
Anemia,3
Hypertension,3
Indoles,3
alpha-beta,3
Humanized,3
Precursor Cell Lymphoblastic Leukemia-Lymphoma,3
Cell Proliferation,3
Proteomics,3
Gene Expression Regulation,3
Oxides,3
Quality-Adjusted Life Years,2
United States,2
Transcriptome,2
Gene Expression Profiling,2
Computational Biology,2
Leukemic,2
Single-Cell Analysis,2
Macrophages,2
Cell Cycle,2
Cytogenetic Analysis,2
Immune Checkpoint Inhibitors,2
Dancing,2
Injections,2
Benzamides,2
Aclarubicin,2
Morpholines,2
SCID,2
High-Throughput Nucleotide Sequencing,2
CD3 Complex,2
Disease Models,2
Animal,2
Longitudinal Studies,2
Sialic Acid Binding Ig-like Lectin 3,2
Immunologic,2
Imidazoles,2
Iodine Radioisotopes,2
Drug Administration Schedule,2
Carrier Proteins,2
Leukopenia,2
COVID-19,2
Vaccination,2
Lenalidomide,2
Cyclin-Dependent Kinases,2
Disease Progression,2
Immunoglobulin Fc Fragments,2
Staurosporine,2
Anthracyclines,2
Antihypertensive Agents,2
Blood Pressure,2
Nausea,2
Multicenter Studies as Topic,2
Time Factors,2
Drugs,2
Chinese Herbal,2
RNA Splicing Factors,2
RNA Splicing,2
Hedgehog Proteins,2
Eukaryotic Initiation Factor-4E,2
Patient Reported Outcome Measures,2
Chromatin,2
Haploidentical,2
Survivors,2
Ciprofloxacin,2
Administration,2
Oral,2
Repressor Proteins,2
Anti-Bacterial Agents,2
Chromosomes,2
Vorinostat,2
Comorbidity,2
Transcription Factors,2
Genomics,2
Blood Platelet Disorders,2
Blood Coagulation Disorders,2
Inherited,2
Maintenance Chemotherapy,2
Hydrazines,2
Cost-Benefit Analysis,2
Mycoses,2
CD19,2
Cytomegalovirus Infections,2
Epstein-Barr Virus Infections,2
Herpesvirus 4,2
Enzyme Inhibitors,2
NF-kappa B,2
Immunosuppressive Agents,2
Lymphoma,2
Oxidative Phosphorylation,2
Whole-Body Irradiation,2
Aldehyde Dehydrogenase,2
Member 1,2
Uridine,2
Anxiety,2
Depression,2
Clinical Trials as Topic,2
Salvage Therapy,2
Signal Transduction,2
Critical Care,2
Critical Illness,2
Telemedicine,2
Recombinant Fusion Proteins,2
Histone Deacetylase Inhibitors,2
Neoplasm Proteins,2
Core Binding Factors,2
Benzimidazoles,2
Phenotype,2
Quinolines,2
Bayes Theorem,2
Glycine,2
Geriatric Assessment,2
Bone Marrow Transplantation,2
Dexamethasone,1
Axl Receptor Tyrosine Kinase,1
Receptor Protein-Tyrosine Kinases,1
Microbiota,1
Invasive Fungal Infections,1
Triazoles,1
Immunologic Factors,1
Subcutaneous,1
Japan,1
Mycophenolic Acid,1
Sirolimus,1
Acetamides,1
Mucositis,1
Down Syndrome,1
Gene Fusion,1
Proto-Oncogene Proteins c-ets,1
Computer-Assisted,1
Hydroxamic Acids,1
Genetic Heterogeneity,1
Cyclin-Dependent Kinase 9,1
B-Cell,1
Drug Evaluation,1
Health,1
Reimbursement,1
Indonesia,1
Cell Transformation,1
Neoplastic,1
Drug Tolerance,1
Machine Learning,1
Cell Adhesion,1
Workflow,1
Image Processing,1
Fish Oils,1
NF-E2-Related Factor 2,1
Insurance,1
Preclinical,1
Azepines,1
Quinuclidines,1
WT1 Proteins,1
Cancer Vaccines,1
RUNX1 Translocation Partner 1 Protein,1
Oncogene Proteins,1
Fusion,1
Translocation,1
Pair 8,1
Fosfomycin,1
Bone Marrow,1
CpG Islands,1
Infusions,1
Intravenous,1
Germ Cells,1
Sex Characteristics,1
Health Status,1
Cognition,1
Drosophila Proteins,1
Chromatin Assembly and Disassembly,1
Preoperative Exercise,1
Tandem Repeat Sequences,1
Gene Duplication,1
Respiratory Insufficiency,1
Sepsis,1
Drug Combinations,1
Music Therapy,1
Stem Cell Transplantation,1
Tablets,1
Area Under Curve,1
Indazoles,1
Protein Serine-Threonine Kinases,1
Liposomes,1
Naphthyridines,1
MAP Kinase Signaling System,1
Fatigue,1
Bispecific,1
Lung Neoplasms,1
HLA-A2 Antigen,1
Genetic Testing,1
HLA Antigens,1
Histocompatibility Antigens Class II,1
Olmesartan Medoxomil,1
Amlodipine Besylate,1
Gene Rearrangement,1
Spiro Compounds,1
Cell Adhesion Molecules,1
Gene Deletion,1
Hematopoietic Stem Cells,1
Immunoglobulins,1
Carcinoma,1
Non-Small-Cell Lung,1
Tyrosine Kinase Inhibitors,1
Surveys and Questionnaires,1
Outpatients,1
Cancer Survivors,1
Polymerase Chain Reaction,1
Cytotoxicity,1
Evolution,1
Molecular,1
Cachexia,1
Weight Loss,1
Metabolomics,1
DNA Methyltransferase 3A,1
DNA (Cytosine-5-)-Methyltransferases,1
DNA Mutational Analysis,1
Agammaglobulinaemia Tyrosine Kinase,1
Aurora Kinases,1
Benzoates,1
Pregnancy,1
Labetalol,1
Postpartum Period,1
Granulocytes,1
Interferon-gamma,1
Social Deprivation,1
Obesity,1
Programmed Cell Death 1 Receptor,1
COVID-19 Vaccines,1
SARS-CoV-2,1
Viral,1
Primary Myelofibrosis,1
Lymphocyte Transfusion,1
Fecal Microbiota Transplantation,1
Feces,1
Cholesterol,1
LDL,1
Dyslipidemias,1
Megakaryoblastic,1
Chromosome Aberrations,1
Bronchiolitis Obliterans Syndrome,1
Myeloid Cell Leukemia Sequence 1 Protein,1
Autologous,1
Olmesartan Medoxomil Drug Combination,1
Hydrochlorothiazide,1
Tetrazoles,1
Essential Hypertension,1
Hyponatremia,1
Transaminases,1
Rosuvastatin Calcium,1
Atorvastatin,1
Molecular Targeted Therapy,1
Uridine Diphosphate,1
HIV-1,1
Fetal Blood,1
HIV Infections,1
Protein Binding,1
Lymphotoxin beta Receptor,1
Interleukin-7,1
Immunogenic Cell Death,1
Erythrocyte Transfusion,1
Hematologic Diseases,1
Hemoglobins,1
CD28 Antigens,1
Glucuronosyltransferase,1
Ribavirin,1
Zinc Finger Protein GLI1,1
Thioredoxins,1
Cytokines,1
Pyridazines,1
Myelogenous,1
BCR-ABL Positive,1
Philadelphia Chromosome,1
Pyrazoles,1
Nitriles,1
United Kingdom,1
Myelodysplastic-Myeloproliferative Diseases,1
East Asian People,1
Benzothiazoles,1
Models,1
Biological,1
Ubiquitin-Protein Ligases,1
Oxidation-Reduction,1
Refractory,1
with Excess of Blasts,1
Mobile Applications,1
Alkylating Agents,1
Estrogens,1
Primary Ovarian Insufficiency,1
Retinoic Acid Receptor alpha,1
Antilymphocyte Serum,1
Mitochondrial,1
Retinal Dehydrogenase,1
Eukaryotic Initiation Factors,1
Nuclear Pore Complex Proteins,1
Retinoblastoma-Binding Protein 2,1
NK Cell Lectin-Like Receptor Subfamily K,1
Multiple Myeloma,1
Ipilimumab,1
Automation,1
CD7,1
Single-Domain Antibodies,1
Asparaginase,1
Polyethylene Glycols,1
Amino Acids,1
Valproic Acid,1
Aldehyde Dehydrogenase 1 Family,1
Lymphopoiesis,1
Lymphotoxin alpha1,1
beta2 Heterotrimer,1
Mesenchymal Stem Cells,1
Calicheamicins,1
Aminoglycosides,1
Stem Cells,1
Alternative Splicing,1
Caspofungin,1
Cell Division,1
KIR,1
Arsenic,1
Docosahexaenoic Acids,1
Eicosapentaenoic Acid,1
Emulsions,1
Feasibility Studies,1
Acetates,1
Lipids,1
Pyruvates,1
Stromal Cells,1
Interleukin-1 Receptor-Associated Kinases,1
Phosphoproteins,1
Protein Isoforms,1
Fluconazole,1
Myeloid Ecotropic Viral Integration Site 1 Protein,1
Penetrance,1
Zebrafish,1
Everolimus,1
TOR Serine-Threonine Kinases,1
Phosphorylation,1
Syk Kinase,1
Immune System Diseases,1
Siblings,1
Non-Hodgkin,1
Methotrexate,1
Sphingosine-1-Phosphate Receptors,1
Neutropenia,1
Genetically Modified,1
Homeodomain Proteins,1
Mammals,1
Allografts,1
Central Nervous System Neoplasms,1
Spinal,1
Myeloablative Agonists,1
Aprepitant,1
Vomiting,1
Antiemetics,1
Interferon alpha-2,1
CD47 Antigen,1
Inbred NOD,1
Phagocytosis,1
Tumor Cells,1
Cultured,1
China,1
Dasatinib,1
Tandem Mass Spectrometry,1
Alpha Particles,1
Radioimmunotherapy,1
CDC2 Protein Kinase,1
Drug Synergism,1
Cyclin-Dependent Kinase-Activating Kinase,1
Immunity,1
Innate,1
Immunological,1
Trans-Activators,1
Tumor Suppressor Proteins,1
ETS Translocation Variant 6 Protein,1
Precision Medicine,1
Activities of Daily Living,1
Newborn,1
Caprylates,1
Sulfides,1
Dibenzocycloheptenes,1
Secretome,1
Caregivers,1
Communication,1
Physician-Patient Relations,1
Patient-Centered Care,1
Decision Making,1
Piperidines,1
Non-Receptor Type 11,1
Granulocyte-Macrophage Colony-Stimulating Factor,1
Allogeneic Cells,1
Age Factors,1
Glycolipids,1
Survival Rate,1
Proportional Hazards Models,1
Differentiation,1
MutL Protein Homolog 1,1
MutS Homolog 2 Protein,1
Nivolumab,1
alpha-Fetoproteins,1
Immunophenotyping,1
Predictive Value of Tests,1
Phosphoric Monoester Hydrolases,1
Protein Tyrosine Phosphatase,1
Secondary Prevention,1
Adaptor Proteins,1
Signal Transducing,1
Base Pair Mismatch,1
DNA Repair,1
Immunohistochemistry,1
Microsatellite Instability,1
Microsatellite Repeats,1
